Drug company founder, executives convicted of bribe scheme that fueled US opioid crisis

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

Jurors on Thursday said they had reached a verdict in the trial of the founder of Insys Therapeutics Inc and four colleagues accused of bribing ...

BOSTON: The founder of drugmaker Insys Therapeutics Inc and four colleagues were found guilty on Thursday of bribing doctors to prescribe an addictive painkiller, helping to drive the U.S. opioid drug abuse crisis.

Prosecutors charged that Kapoor oversaw a wide-ranging scheme to bribe doctors nationwide by retaining them to act as speakers at sham events at restaurants ostensibly meant to educate clinicians about its fentanyl spray, Subsys. Michael Babich, who resigned as Insys' chief executive in 2015, pleaded guilty to his role in the scheme in January and became a key witness for prosecutors.The U.S. Food and Drug Administration approved Subsys in 2012 only for use in treating severe cancer pain. Yet prosecutors claimed doctors who took bribes often prescribed Subsys to patients without cancer, helping boost sales for Chandler, Arizona-based Insys.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 6. in FR

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Drug company founder, execs convicted of bribe scheme that fueled US opioid epidemicJurors on Thursday said they had reached a verdict in the trial of the founder of Insys Therapeutics Inc and four colleagues accused of bribing ...
La source: ChannelNewsAsia - 🏆 6. / 66 Lire la suite »